Doctor, drug industry relationship under scrutiny
Broadcast: Midmorning, 03/26/2007, 9:00 a.m.
A new report in the Journal of the American Medical Association shows some Minnesota doctors receive tens of thousands of dollars in speaking fees and other legal payments from drug companies. Is this compensation affecting their objectivity?
- Robert Meiches, MD: CEO of the Minnesota Medical Association.
- Cody Wiberg: Executive director of the Minnesota Board of Pharmacy.
- Michael Oldani: Assistant professor of medical anthropology at University of Wisconsin-Whitewater. He previously worked as a pharmaceutical sales representative.